Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
  Senores Pharmaceuticals Ltd
Registered Office: #.1101-1103 11th Flr South Twr,Ambali Bopal Road , Ahmedabad - 380054 , Gujarat , India.
Phone : +91-79-2999 9857   Fax:
Email :  cs@senorespharma.com  
Website :  www.senorespharma.com
Initial public offering of up to [*] equity shares of face value of 10 each ("Equity Shares") of Senores Pharmaceuticals Limited ("The Company" or the "Issuer") for cash at a price of [*] per equity share (including a share premium of [*] per equity share) ("Offer Price") aggregating up to [*] crores (the "Offer"). The offer comprises of a fresh issue of upto [*] equity shares by the company aggregating upto 500.00 crores (the "Fresh Issue") and an offer for sale of up to 2,100,000 equity shares (the "Offered Shares") aggregating up to [*] crores (the "Offer for Sale"), comprising up to 250,000 equity shares aggregating to [*] crores by Swapnil Jatinbhai Shah, up to 550,000 equity shares aggregating to [*] crores by Ashokkumar Vijaysinh Barot, up to 300,000 equity shares aggregating to [*] crores by Sangeeta Mukur Barot and up to 1,000,000 equity shares aggregating to [*] crores by Prakash M Sanghvi (the "Selling Shareholders"). The offer shall constitute [*] % of the post-offer paid-up equity share capital of the company. The offer includes a reservation of up to 75,000 equity shares, aggregating up to [*] crores (constituting [*] of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". Price Band: 372 to 391 per equity share of face value of 10 each. The Floor price is 37.20 times the face value of the equity shares and cap price is 39.10 times the face value of the equity shares. Bid can be made for a minimum of 38 equity shares and in multiples of 38 equity shares.

Issue Money Payable On
Opens On Closes On Application Allotment
20-Dec-24 24-Dec-24 Rs372.00-391.00 Rs0.00-0.00
Minimum Application for shares in Nos :38  Further Multiples of :38

  RsCr Lead Managers to the Issue
Project Cost 0.00
Ambit Pvt Ltd
Project Financed through Current Offer 578.12  
Post Issue Equity Share Capital 46.05  
Issue Price Rs372.00  
 
Projects
 Funding the capital expenditure requirements by investment in of one of your its subsidiary Havix,for setting up a mfg facility for the production of sterlie injection in its Atlanta Facility Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes
 Re-payment/pre-payment in full or in part of certain borrowings availed by the company and its subsidiary namely Havix Ratnatris and PSI Investment in its subsidiary namely Havix for re-payment/pre-payment in full or in part of certain borrowings availd by the subsidiaries
 Funding the working capital requirements of the company and its subsidiary namely SPI ad Ratnatris Investment in its subsidiary namely SPI and Ratnatri to fund their working capital requirements
Promoted By
 Swapnil Jatinbhai
 Ashokkumar Vijaysingh Barot
 Anar Swapnil Shah
Listing At
 BSE 
 NSE 
Registrar to the Issue
 Link Intime India Pvt Ltd